Centogene NV
NASDAQ:CNTG
Centogene NV
NASDAQ:CNTG
Price:
0.3898 USD
4.22%
Market Closed
Updated:
May 29, 2024
Centogene NV
Operating Expenses
|
Centogene NV
Operating Expenses Peer Comparison
Comparables:
BNTX
MOR
CVAC
IMTX
BIO
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Centogene NV
NASDAQ:CNTG
|
Operating Expenses
-€45.7m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Operating Expenses
-€2.3B
|
CAGR 3-Years
-66%
|
CAGR 5-Years
-69%
|
CAGR 10-Years
N/A
|
|
|
MorphoSys AG
XETRA:MOR
|
Operating Expenses
-€611.1m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-25%
|
|
|
CureVac NV
NASDAQ:CVAC
|
Operating Expenses
-€207.2m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Immatics NV
NASDAQ:IMTX
|
Operating Expenses
-€155.7m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
|
Biotest AG
XETRA:BIO
|
Operating Expenses
-€174.6m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-1%
|
See Also
What is Centogene NV's Operating Expenses?
Operating Expenses
-45.7m
EUR
-45.7m
EUR
Based on the financial report for Dec 31, 2023, Centogene NV's Operating Expenses amounts to -45.7m EUR.
What is Centogene NV's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-8%
-8%
Over the last year, the Operating Expenses growth was 18%. The average annual Operating Expenses growth rates for Centogene NV have been 8% over the past three years , -8% over the past five years .
You don't have any saved screeners yet
